Doya Medical Ltd. is a biotech company that developed a non-invasive delivery technology and stent product for the treatment of Otitis Media with Effusion (OME).
With 2 granted patents in the US and in Europe, and a validated animal model Doya Medical Ltd. is now seeking investment that will take us to clinical trials.
Doya Medical is targeting a huge market of about 1 million ear tubes surgeries that are performed on children every year in North America alone. We aim to replace these surgeries by using an alternative device and the human body’s natural physiology.
The eStent of Doya Medical Ltd. is an active stent used to drain fluid from the ear naturally and without surgery. Our kit includes the eStent and an optically guided delivery system for insertion into the Eustachian Tube.
The overall cost of Tympanostomy Tube surgery is estimated to reach US$4B (Procedure Cost US$3547 + complication cost US$500). We Aime to change that with a patented, natural, non-intrusive solution.
Like the heart stent, the eStent represents a revolution in treating OME-Otitis Media with Effusion.
eStent places a stent in the Eustachian Tube in order to drain fluid naturally, supporting our body’s anatomy, rather than cutting the ear drum and inserting a tube.
With our eStent you can go swimming, hear better and have less sensitivity to changes in altitude.
Our experienced team has been developing the patented eStent and now has an animal model.
The Current Treatment of OME is Tympanostomy (Grommet) Tympanostomy – Plastic grommets are inserted through the ear-drum under anesthesia.
Benefits of the New eStent Procedure are numerous starting from it not requiring a surgical intervention and significantly improve the Quality of Life (QoL) for both child and parents
Company’s Keywords:
<2
<
<2015
Your request has been submitted successfully.
Own or work here?